AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15040503
Drug: Acetazolamide 250
RxNorm normalized name: acetazolamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 250 mg plus medroxyprogesterone 30 mg twice daily
Trial: 15040503
Drug: Acetazolamide 250
RxNorm normalized name: acetazolamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 250 mg plus placebo twice daily
Trial: 31115552
Drug: Nutraceutical supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutraceutical supplements (NS)
Trial: 16340560
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment followed by delayed laparoscopic cholecystectomy (DLC)
Trial: 3636340
Drug: Timentin (ticarcillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timentin (ticarcillin 3 g plus potassium clavulanate 200 mg)
Trial: 3636340
Drug: Piperacillin (125-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin (125-200 mg/kg per day)
Trial: 29229498
Drug: Once-daily, modified-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily, modified-release hydrocortisone
Trial: 22276959
Drug: Drug Burden
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Burden Index (DBI) low category (n=260)
Trial: 22276959
Drug: Drug Burden
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Burden Index (DBI) high category (n=153)
Trial: 19011281
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 2.8 g/day
Trial: 19011281
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (DHA) 2.9 g/day
Trial: 10656230
Drug: Adding metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adding metformin
Trial: 24941816
Drug: Ketamine 1
RxNorm normalized name: ketamine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1 mg/(kg x h)
Trial: 20621660
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg OpunDia
Trial: 12391494
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous prednisone in combination with intramuscular polyvitaminic therapy (group A)
Trial: 12391494
Drug: Polyvitaminic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyvitaminic therapy alone (group B)
Trial: 2363111
Drug: Disodium monofluorophosphate
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium monofluorophosphate with calcium salts (100 mg disodium monofluorophosphate, 500 mg calcium)
Trial: 9205772
Drug: Control preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control preparation (not specified)
Trial: 28734759
Drug: Nivolumab 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 3 mg/kg every 2 weeks until disease progression, death, unacceptable toxic effects, or withdrawal from study.
Trial: 25887365
Drug: Non-pharmacological multidisciplinary
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological multidisciplinary face-to-face treatment program (6 weeks, 7 group sessions)
Trial: 25887365
Drug: Telephone-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based treatment program (6 weeks, 2 group sessions + 4 telephone contacts)
Trial: 25887365
Drug: Non-pharmacological multidisciplinary
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological multidisciplinary face-to-face treatment program
Trial: 11589530
Drug: Sertraline 50
RxNorm normalized name: sertraline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 50 to 200 mg/day
Trial: 6757621
Drug: Polyunsaturated phosphatidyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyunsaturated phosphatidyl choline therapy (3 g/day)
Trial: 6757621
Drug: Normal maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal maintenance immunosuppressive therapy
Trial: 22893167
Drug: Cognitive-behavioral conjoint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral conjoint therapy for PTSD (15 sessions)
Trial: 19922797
Drug: Post-PCI statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-PCI statin therapy
Trial: 10639356
Drug: Teicoplanin (TEC)
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin (TEC) 400 mg in 100 ml of saline as a 5‐min infusion into a foot vein of the leg to be operated on, administered immediately after the tourniquet was inflated to 400 mm Hg.
Trial: 1906399
Drug: Aspirin (1300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1300 mg/day)
Trial: 6614965
Drug: 20% 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% 5-fluorouracil (5-FU) ointment applied topically for four weeks
Trial: 22191426
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17β‐estradiol in non-smokers
Trial: 22191426
Drug: Estrogen group
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen group (1 mg 17β‐estradiol)
Trial: 21327805
Drug: Melatonin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.1 mg/kg
Trial: 20668840
Drug: Melatonin 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.15 mg/kg
Trial: 18001879
Drug: Cetirizine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 25 mg (CE) with alcohol 0.8 g/kg (AL)
Trial: 18001879
Drug: Alcohol 0.8
RxNorm normalized name: isopropyl alcohol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.8 g/kg (AL)
Trial: 1773412
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL of iohexol 240 (24 g iodine)
Trial: 31350646
Drug: No Radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Radiotherapy (RT) administered to 141 patients (17.3%)
Trial: 24935072
Drug: ticagrelor 45
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ticagrelor 45 mg bid
Trial: 24935072
Drug: ticagrelor 90
RxNorm normalized name: ticagrelor 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ticagrelor 90 mg bid
Trial: 15302800
Drug: Rofecoxib (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (25 mg) daily for 6 months
Trial: 2668979
Drug: Moclobemide 50
RxNorm normalized name: moclobemide
DrugBank: Moclobemide (DB01171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide 50 mg capsules
Trial: 129494
Drug: Oral tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tetracycline (500 mg/day)
Trial: 129494
Drug: Topical tetracycline
RxNorm normalized name: TETRACYCLINE HYDROCHLORIDE 30 mg in 1 mL TOPICAL SPRAY [Tetracyte Topical Tetracycline Hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tetracycline (0.5% solution applied twice daily)
Trial: 17165243
Drug: Immediate-release nicotinic
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release nicotinic acid
Trial: 7573093
Drug: Sustained-release nicotinic
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release nicotinic acid
Trial: 8251351
Drug: Mantoux test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mantoux test (tuberculin injection)
Trial: 20421151
Drug: Proton beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton beam therapy and capecitabine (825 mg/m² b.i.d. for 10 days)
Trial: 20421151
Drug: Proton beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton beam therapy and capecitabine
Trial: 18653493
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg + Dexamethasone 8 mg
Trial: 8222739
Drug: Indomethacin suppository
RxNorm normalized name: indomethacin Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin suppository (100 mg)
Trial: 3100675
Drug: Codeine phosphate
RxNorm normalized name: Codeine Phosphate
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine phosphate 15 mg
Trial: 24469645
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (daily hydration of 2500 mL, ciprofloxacin, diclofenac sodium, spasmolytic agent)
Trial: 16101362
Drug: Surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical periodontal treatments (four different surgical procedures)
Trial: 1453290
Drug: Group II:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group II: 1 gram of Cefazolin IV and 1 gram in saline irrigation solution
Trial: 6377793
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of methyldopa/hydrochlorothiazide/amiloride (M/HCT/A)
Trial: 29893596
Drug: Placebo (inert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inert pills)
Trial: 18614728
Drug: Porridge with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porridge with energy density of 0.5 kcal/g
Trial: 18614728
Drug: Porridge with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porridge with energy density of 1.0 kcal/g
Trial: 8949813
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg
Trial: 8949813
Drug: Propofol 3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3.3 mg
Trial: 23761651
Drug: 30 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/d of hazelnuts
Trial: 15996416
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied two times per week for 16 weeks
Trial: 8843209
Drug: Pentoxifylline (1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (1800 mg/day, timed-release formulation)
Trial: 1355585
Drug: Somatostatin analogues
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin analogues (e.g., octreotide)
Trial: 31368267
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia (PCEA, Sufentainil + 0.1% Ropivacaine hydrochloride, 5 µg/mL at L3‐L4 interspace)
Trial: 31368267
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection of Ropivacaine (0.2%, 1 mL/acupoint at LI4 and SP6)
Trial: 22826982
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection therapy with diluted epinephrine (group I)
Trial: 22826982
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of epinephrine and hemoclips (group II)
Trial: 18506129
Drug: Propionyl-L-carnitine (PLC)
RxNorm normalized name: glycine propionyl-L-carnitine
DrugBank: Levocarnitine propionate (DB15980)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (PLC) therapy at a dosage of 1,200 mg PLC in 250 cc of physiological solution for 5 days a week for 4 weeks
Trial: 18506129
Drug: Propionyl-L-carnitine (PLC)
RxNorm normalized name: glycine propionyl-L-carnitine
DrugBank: Levocarnitine propionate (DB15980)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (PLC) in association with pulsed muscular compression therapy (Vascupump) for 5 sessions a week for 4 weeks
Trial: 18506129
Drug: Pulsed muscular
RxNorm normalized name: Orchis mascula whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed muscular compression therapy (Vascupump) only
Trial: 15898936
Drug: Systemic amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic amoxicillin plus metronidazole and CHX irrigation
Trial: 15898936
Drug: Subgingival scaling
RxNorm normalized name: wing scale pollen extract
DrugBank: Atriplex canescens pollen (DB10767)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgingival scaling without adjunctive therapy (control group)
Trial: 8983866
Drug: High fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fat meal with insulin (peak insulin 86.1 ± 10.1 m-units/l)
Trial: 6959168
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of methadone
Trial: 31881956
Drug: Guided-care (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided-care (with gene-drug interactions)
Trial: 29417694
Drug: Duloxetine (DLX,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (DLX, 60 mg once daily)
Trial: 26972745
Drug: Pill placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill placebo and PE
Trial: 15801505
Drug: Non-elaborated words
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-elaborated words (treatment group)
Trial: 15801505
Drug: Elaborated words
RxNorm normalized name: Wood creosote
DrugBank: Wood creosote (DB13271)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elaborated words (treatment group)
Trial: 6663643
Drug: Structured couples
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured couples treatment program
Trial: 29570535
Drug: Daily measurements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily measurements of vital signs, body weight, and fluid intake and output
Trial: 18292445
Drug: Perioperative celecoxib
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative celecoxib (2 celecoxib 200 mg p.o. 30‐90 min before surgery, and two placebos after surgery, followed by one celecoxib 200 mg p.o. BID on postoperative day #1, #2, and #3)
Trial: 16548286
Drug: Dexmedetomidine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine administered prior to anesthesia
Trial: 16548286
Drug: Dexmedetomidine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine administered during transanesthesia
Trial: 11191783
Drug: Fluid replacement
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid replacement (200 or 250 ml of warm water at approximately 35 degrees C) during light exercise (L/F)
Trial: 11191783
Drug: No fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No fluid (NF) during light exercise (L/NF)
Trial: 11191783
Drug: Fluid replacement
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid replacement (F) during light exercise (L)
Trial: 11191783
Drug: Fluid replacement
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid replacement during light exercise (L/F)
Trial: 11191783
Drug: No fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No fluid during light exercise (L/NF)
Trial: 8255440
Drug: Branched-chain amino
RxNorm normalized name: Branched-chain amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branched-chain amino acids (BCAA) - L‐leucine 12 g, L‐isoleucine 6 g, L‐valine 6 g daily
Trial: 3515261
Drug: Intramuscular ritodrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ritodrine followed by oral ritodrine treatment and bed rest
Trial: 15333424
Drug: conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional therapy
Trial: 20379004
Drug: Drug alteration
RxNorm normalized name: SLICK ALTERATION DISRUPTING BOS TAURUS G.(NC_037347.1) FS(39099129-39099368) IN EXON 9 OF PRLR GENE IN BOS TAURUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug alteration (DA) group
Trial: 17943420
Drug: Nalbuphine (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine (2.5, 5, 10, or 20 mg)
Trial: 17943420
Drug: Naloxone (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.2 or 0.4 mg, ED(50) estimated at 0.5 mg)
Trial: 17943420
Drug: Nalbuphine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine and Naloxone (in combination)
Trial: 2006724
Drug: midazolam/flumazenil (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam/flumazenil (15 mg midazolam, 0.5 mg flumazenil after 60 min)
Trial: 23635869
Drug: Kava (120/240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kava (120/240 mg of kavalactones per day)
Trial: 3018603
Drug: Enalapril (10‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10‐20 mg b.i.d.)
Trial: 23819698
Drug: Aclidinium 400
RxNorm normalized name: aclidinium 400 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium 400 μg twice daily
Trial: 20112485
Drug: 5-step manipulation
RxNorm normalized name: STEP 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-step manipulation and traction (treatment group)
Trial: 17484080
Drug: Intravenous indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous indomethacin (0.2 mg/kg at 12‐hour intervals)
Trial: 17484080
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen suspension (10 mg/kg initial dose, followed by two doses of 5 mg/kg each after 24 and 48 hours)
Trial: 19255990
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen suspension
Trial: 11818602
Drug: Sedation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedation with adjunct hypnosis
Trial: 11818602
Drug: Standard intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intravenous conscious sedation
Trial: 30616547
Drug: BITS7201A (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BITS7201A (150 mg SC, 300 mg SC, 600 mg SC)
Trial: 10208786
Drug: Intra-aortic balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-aortic balloon pump therapy
Trial: 25287767
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy without intra-aortic balloon pump
Trial: 28187983
Drug: Intensified therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified therapy
Trial: 27911988
Drug: Mirabegron (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (25-50 mg)
Trial: 27911988
Drug: Solifenacin (2.5-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin (2.5-5 mg)
Trial: 20542324
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy (OIT) using a rush protocol with roasted peanut for 7 days
Trial: 16203884
Drug: Open operative
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Open operative treatment
Trial: 12519844
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg twice daily for 3 months, then 1000 mg twice daily for 3 months; n = 8)
Trial: 10930893
Drug: Rifaximin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (400 mg b.d per 7 days)
Trial: 10930893
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (400 mg b.d per 7 days)
Trial: 6140440
Drug: Regular alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular alcohol consumption (up to 80 g daily)
Trial: 31035190
Drug: Clonazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (0.5 mg/day at bedtime)
Trial: 25472768
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (long/intermediate acting)
Trial: 19549615
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (ELE + prolotherapy)
Trial: 6173514
Drug: Phentolamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentolamine infusion after placebo
Trial: 6173514
Drug: Phentolamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentolamine infusion after prazosin (alpha 1-blocker)
Trial: 29984691
Drug: 6-monthly Periodontal
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 6-monthly Periodontal Instrumentation (PI)
Trial: 29984691
Drug: 12-monthly PI
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 12-monthly PI